Both bioinformatics and clinical data showed that Piezo1 expression was upregulated in all histological subtypes of glioma, from LGG to GBM, and that its expression was positively correlated with malignancy (Chen et al., 2018; Zhou et al., 2020). This evidence concerns the gene PIEZO1 and glioma.